Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China.

Shi R, Xie Q, Gang X, Lun J, Cheng L, Pantuck A, Rao J.

J Urol. 2008 Feb;179(2):610-5. Epub 2007 Dec 21.

PMID:
18082217
2.
3.

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.

Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG, Crawford ED, Foster HE Jr, Kaplan SA, McCullough A, Andriole GL, Naslund MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT; Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group.

JAMA. 2011 Sep 28;306(12):1344-51. doi: 10.1001/jama.2011.1364. Erratum in: JAMA. 2012 Jun 13;307(22):2374.

4.

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.

Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L.

J Urol. 2008 Oct;180(4):1228-34. doi: 10.1016/j.juro.2008.06.079. Epub 2008 Aug 22.

PMID:
18722631
6.

The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.

Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, Montorsi F; CombAT Study Group.

J Urol. 2008 Feb;179(2):616-21; discussion 621. Epub 2007 Dec 21. Erratum in: J Urol. 2008 Sep;180(3):1191.

PMID:
18082216
7.

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S.

J Urol. 2010 Mar;183(3):1092-7. doi: 10.1016/j.juro.2009.11.014. Epub 2010 Jan 25.

PMID:
20092847
8.

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.

Gerber GS, Kuznetsov D, Johnson BC, Burstein JD.

Urology. 2001 Dec;58(6):960-4; discussion 964-5.

PMID:
11744467
9.

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S.

J Urol. 2013 Jan;189(1 Suppl):S135-40. doi: 10.1016/j.juro.2012.11.025.

PMID:
23234619
11.

Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.

Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernández Fernández E; European Silodosin Study Group.

Eur Urol. 2011 Mar;59(3):342-52. doi: 10.1016/j.eururo.2010.10.046. Epub 2010 Nov 10.

PMID:
21109344
12.

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.

Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA.

Urology. 1998 Jun;51(6):1003-7.

PMID:
9609640
13.

The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial.

Andriole GL, McCullum-Hill C, Sandhu GS, Crawford ED, Barry MJ, Cantor A; CAMUS Study Group.

J Urol. 2013 Feb;189(2):486-92. doi: 10.1016/j.juro.2012.09.037. Epub 2012 Dec 14.

14.

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.

Lopatkin N, Sivkov A, Walther C, Schläfke S, Medvedev A, Avdeichuk J, Golubev G, Melnik K, Elenberger N, Engelmann U.

World J Urol. 2005 Jun;23(2):139-46. Epub 2005 Jun 1.

PMID:
15928959
15.

Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.

McVary KT, Rademaker A, Lloyd GL, Gann P.

J Urol. 2005 Oct;174(4 Pt 1):1327-433.

PMID:
16145413
16.

Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.

Yokoyama O, Yoshida M, Kim SC, Wang CJ, Imaoka T, Morisaki Y, Viktrup L.

Int J Urol. 2013 Feb;20(2):193-201. doi: 10.1111/j.1442-2042.2012.03130.x. Epub 2012 Sep 7.

17.

A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter study.

Narayan P, Trachtenberg J, Lepor H, Debruyne FM, Tewari A, Stone N, Das S, Jimenez-Cruz JF, Shearer R, Klimberg I, Schellhammer PF, Costello AJ.

Urology. 1996 Apr;47(4):497-504.

PMID:
8638357
18.

Saw palmetto for benign prostatic hyperplasia.

Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL.

N Engl J Med. 2006 Feb 9;354(6):557-66.

19.

A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.

McVary KT, Roehrborn CG, Chartier-Kastler E, Efros M, Bugarin D, Chen R, Patel A, Haag-Molkenteller C.

J Urol. 2014 Jul;192(1):150-6. doi: 10.1016/j.juro.2014.02.004. Epub 2014 Feb 7. Erratum in: J Urol. 2015 Jan;193(1):374.

PMID:
24508634
20.

Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Roehrborn CG, Chapple C, Oelke M, Cox D, Esler A, Viktrup L.

J Urol. 2014 Apr;191(4):1045-50. doi: 10.1016/j.juro.2013.10.074. Epub 2013 Oct 25.

PMID:
24445278

Supplemental Content

Support Center